Literature DB >> 7278493

High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics.

Y M Peng, T P Davis, D S Alberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7278493     DOI: 10.1016/0024-3205(81)90329-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Blood and tissue concentrations of Bisantrene measured by a simple fluorometric assay.

Authors:  M Buck; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Regional targeting of bisantrene by directed intravascular precipitation.

Authors:  J S Kovach; M Buck; T Tsukamoto; A Odegaard; M M Lieber
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay.

Authors:  R Ludwig; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors.

Authors:  C B Pratt; J A Sinkule; E Etcubanas; E C Douglass; D B Crom; K Choi; L Avery
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

6.  Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote.

Authors:  R T Dorr; Y M Peng; D S Alberts
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

7.  In vivo and in vitro metabolism of the new anticancer drug bisantrene.

Authors:  Y M Peng; D S Alberts; T P Davis
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.